Return to content in this issue

 

Multi-tool approach for high risk aspirin desensitization in a pregnant woman

Pérez Rodríguez E, Martínez Tadeo JA, Hernández Santana G, Iglesias Souto FJ, Rodríguez Plata E, Barrios Recio J, Callero Viera A

Servicio de Alergología, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife

J Investig Allergol Clin Immunol 2022; Vol. 32(3)
doi: 10.18176/jiaci.0734

Key words: Omalizumab, Aspirin Desensitization, Ketorolac Nasal Challenge, NSAID Hypersensitivity, NERD